"When you say ROI, do you mean return on investment or risk of inaction?" Regarding new technologies, human decision-making is a complicated phenomenon. This is...
Read moreAlthough vaccine trials are far from the first candidates pharmaceutical companies have in mind when thinking about clinical trial supply optimization, there's...
Read moreEarlier this year, N-SIDE's Alexis Davin and Antoine Remiot teamed up with AstraZeneca's Britta Claesson to present an interesting case study during the annual...
Read moreIn recent years, challenges such as COVID-19 have pushed pharmaceutical companies to find innovative solutions to accelerate their clinical trial timelines.
Read moreClinical trial supply optimization is the process of supplying the right amount of investigational medicinal product (IMP) and comparators to all trial sites so...
Read moreAre you struggling to smartly aggregate your clinical supply data ? Do you want to transform this data into actionable insights?
Read moreJoin us at the digital edition of the Clinical Trial Supply conference. Due to the COVID-19 situation, the event will be hosted virtually :
Read moreAchieving an agile and optimal clinical trial supply strategy is challenging – clinical trial supply managers must forecast for unpredictable demand while at the...
Read moreCritical decisions are taken during protocol design. It is essential to maintain patient centricity and respect site constraints, but it is also an opportunity...
Read more